Indeed, in a cohort of CRC patients, poor EMILIN-2 expression associated with increased levels of S100P [51], a marker of poor prognosis whose expression together with that of APOBEC3G, CD133, LIPC correlates with increased CRC hepatic metastasis [68]. The gene discussed is LIPC; the disease is colorectal carcinoma.